VSee Health Reports 98% Revenue Growth to $3.39 Million, Net Loss Increases to $2.61 Million

VSee Health, Inc. reported significant financial developments in its latest 10-Q filing for the quarter ending June 30, 2025. The company generated total revenues of $3.39 million for the three months ended June 30, 2025, marking a 98% increase from $1.71 million in the same period last year. For the six months, revenues reached $6.71 million, up 101% from $3.33 million in the prior year. The growth was primarily driven by the acquisition of iDoc, which contributed significantly to patient and telehealth fees, alongside increased professional services and technical engineering fees.

Despite the revenue growth, VSee Health reported a net loss of $2.61 million for the three months ended June 30, 2025, compared to a loss of $666,102 in the same quarter of 2024. For the six-month period, the net loss escalated to $6.57 million, a substantial increase from $571,352 in the previous year. The increase in losses was attributed to higher operating expenses, which surged by 125% to $3.84 million in the latest quarter, driven by increased compensation and general administrative costs related to the iDoc acquisition and the recapitalization with Digital Health Acquisition Corp.

Operationally, VSee Health has seen a notable increase in customer engagement metrics. The company reported a significant rise in patient fees and telehealth services, with patient fees alone contributing $1.19 million in the latest quarter. The total customer count and user statistics have also improved, reflecting the company's strategic focus on expanding its telehealth offerings. The company has been actively pursuing new contracts with larger hospitals and entering new markets, which is expected to drive future revenue growth.

In terms of financial health, VSee Health's total assets decreased to $18.21 million as of June 30, 2025, down from $19.99 million at the end of 2024. The company’s liabilities increased significantly, with total liabilities reported at $23.95 million, compared to $20.01 million at the end of the previous year. This increase was largely due to higher accounts payable and accrued liabilities, as well as deferred revenue. The company continues to face challenges related to liquidity and has indicated that it is in negotiations for additional financing to support its working capital needs.

Looking ahead, VSee Health remains optimistic about its growth trajectory, emphasizing its commitment to enhancing its telehealth platform and expanding its market presence. The company is focused on leveraging its technology to improve patient care and operational efficiency, while also addressing its financial challenges through strategic financing initiatives. The management has expressed confidence in the potential for future revenue growth driven by its robust pipeline and ongoing market demand for telehealth solutions.